Article

Patient presents with pain, diplopia, and proptosis

A 54-year-old male pre­sented to the Bascom Palmer Emergency Room complaining of pain, double vision, and increasing proptosis of his right eye over the past 4 to 6 weeks.

A 54-year-old male presented to the Bascom Palmer Emergency Room complaining of pain, double vision, and increasing proptosis of his right eye over the past 4 to 6 weeks. He also complained of periorbital redness and temple swelling. He denied any change in vision, nausea, vomiting, fevers, chills, or photophobia.

His medical history was significant for hypertension, gout, and dyslipidemia. His social history was significant for a 25-pack-year history of tobacco use and social alcohol use. He was married with two children and was allergic to aspirin. Review of systems was unremarkable except for occasional joint and muscle pains.

Examination

Anterior segment exam of the right eye was significant for temporal conjunctival injection and chemosis. Dilated fundus examination of the right eye was significant for slight blurring of the nasal optic disc margin. There was no optic nerve pallor, hemorrhage, choroidal folds, or retinal striae. Funduscopic examination of the left eye was unremarkable.

Differential diagnosis

Case continued

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.